NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ:EPIX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ESSA securities between December 12, 2023 and October 31, 2024, both dates inclusive (the "Class Period").

NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Spire Global, Inc. ("Spire" or "the Company") (NYSE:SPIR). Investors who purchased Spire securities prior to May 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SPIR.

NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI). Investors who purchased Inari securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NARI.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE:OMI). Investors who purchased Owens & Minor securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OMI.

NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Customers Bancorp, Inc. ("Customers Bancorp" or "the Company") (NYSE:CUBI). Investors who purchased Customers Bancorp securities prior to March 1, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CUBI.

NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equinix, Inc. ("Equinix" or "the Company") (NASDAQ:EQIX). Investors who purchased Equinix securities prior to May 3, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/EQIX.

NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Domino's Pizza, Inc. ("Domino's" or "the Company") (NYSE:DPZ). Investors who purchased Domino's securities prior to December 7, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/DPZ.

NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sun Communities, Inc. ("Sun Communities" or "the Company") (NYSE:SUI). Investors who purchased Sun Communities securities prior to February 28, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SUI.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and Monogram Health announce expansion of comprehensive kidney care program.

Investors looking for tax-advantaged income or returns have generally focused on muni bonds. BOXX is a newer entrant in this space, with a very different strategy, basically synthetic t-bills. BOXX's approach results in much more stable returns, with higher returns in the past.

AEE continues to increase shareholder value as its board of directors raises dividends by nearly 6%.

These ETF strategies may help you beat hot inflation.

A handful of strong companies have been hit hard to start 2025 that investors might want to consider buying for long-term upside. The two stocks we look at today (Advanced Micro Devices and Deckers Brands) are trading 45% and 30% below their respective highs.

Telus International (TIXT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.26 per share a year ago.

US Foods (USFD) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $0.64 per share a year ago.

Onity Group (ONIT) came out with quarterly earnings of $1.39 per share, missing the Zacks Consensus Estimate of $2.34 per share. This compares to earnings of $1.44 per share a year ago.

I missed the 60% BABA rally as I dithered, while hanging on to Pinduoduo stock. Lessons were learned. Alibaba's reported tie up with Apple to launch Apple Intelligence in China has validated its AI and cloud capabilities. Alibaba is a well-oiled machine with a strong domestic e-commerce base and global markets that is less immune to headwinds now facing Temu and Shein.

Ingredion Ventures, Lever VC, and Sucden Ventures join existing key investors to close an $18M funding round. DAVIS, Calif.

Sprout Social Influencer Marketing revolutionizes how brands discover, activate and scale influencer partnerships Sprout Social Influencer Marketing revolutionizes how brands discover, activate and scale influencer partnerships

Shares of CVS Health Corporation NYSE: CVS experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's stock price increase comes after a period of decline, causing investors to question whether this is a temporary upswing or a sign of a genuine turnaround.